by admin | Feb 12, 2018 | Press Releases
Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree IRVINE, CA (PRWEB) October 24, 2013 Proove Biosciences, the leader in personalized pain medication innovation, is proud to be a Silver Sponsor partner of HC DrugFree and...
by admin | Feb 12, 2018 | Press Releases
Proove Biosciences’ Presented Research on the Predictive Risk of Workers Compensation Claims Extending Beyond One Year Irvine, CA (PRWEB) April 15, 2014 Proove Biosciences, the leader in Personalized Pain Medicine testing services, exhibited and presented three...
by admin | Feb 12, 2018 | Press Releases
(PRWEB) APRIL 07, 2015 Proove Biosciences a commercial and research leader in Personalized Medicine, is excited to announce the launch of Proove Opioid Response – the world’s first clinical laboratory test to predict responders to opioid pain medications....
by admin | Feb 12, 2018 | Press Releases
Proove Biosciences, a commercial and research leader in personalized medicine, is excited to announce their partnership with the Keck Medicine of the University of Southern California(USC) Pain Center to study the genetics of chronic pain. The T.R.O.J.A.N. Study...
by admin | Feb 12, 2018 | Press Releases
IRVINE, CA (PRWEB) MARCH 30, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce the expansion of its salesforce. Building on record growth, Proove Biosciences is expanding its network of authorized...
by admin | Feb 12, 2018 | Press Releases
Proove Biosciences Closes on the Acquisition of Pain Genetics Firm Algynomics Proove Biosciences, Inc. today announced it has closed on a definitive agreement to acquire Algynomics, a research-stage pain diagnostics company. The Algynomics platform and its patient...
Recent Comments